Understanding Suboptimal Human Papillomavirus Vaccine Uptake Among Ethnic Minority Girls

Bastani, Roshan; Glenn, Beth A.; Tsui, Jennifer; Chang, Lin; Marchand, Erica; Taylor, Victoria M.; Singhal, Rita

doi:10.1158/1055-9965.epi-11-0267

Cited by 116 publications

(135 citation statements)

References 23 publications

Supporting

Mentioning

119

Contrasting

Order By: Relevance

“…Several studies have shown that parental knowledge and awareness of HPV vaccine is a strong predictor of vaccine receipt or intention to vaccinate. 13,14 High attitude and belief scores were associated with HPV series completion as well. A cohort study by Fishman et al that only measured HPV knowledge among parents and adolescents found knowledge was not a significant predictor of vaccination behavior and suggested that beliefs and attitudes are more predictive of vaccination behaviors.…”

Section: Discussionmentioning

confidence: 99%

“…This study is unique in that it focuses on a racially and economically diverse sample of adolescents coming from a mix of urban and rural schools, whereas previous HPV studies with parents were conducted prior to ACIP recommendations for HPV vaccination of males, focused on female adolescents only, or relied primarily on health care facilities for recruitment. [12][13][14][15] by Medicaid (59.8%, n D 410) and were enrolled in middle school (63.6%, n D 436) ( Table 1). Only 48.5% (n D 333) of adolescents had received one dose of the HPV vaccine ( Table 1).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Human papillomavirus vaccination among adolescents in Georgia

Underwood

Weiss

Gargano

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Human papillomavirus (HPV) vaccination coverage for adolescent females and males remains low in the United States. We conducted a 3-arm randomized controlled trial (RCT) conducted in middle and high schools in eastern Georgia from 2011-2013 to determine the effect of 2 educational interventions used to increase adolescent vaccination coverage for the 4 recommended adolescent vaccines: Tdap, MCV4, HPV and influenza. As part of this RCT, this article focuses on: 1) describing initiation and completion of HPV vaccine series among a diverse population of male and female adolescents; 2) assessing parental attitudes toward HPV vaccine; and 3) examining correlates of HPV vaccine series initiation and completion. Parental attitude score was the strongest predictor of HPV vaccine initiation among adolescents (adjusted odds ratio (aOR): 2.08; 95% confidence interval (CI): 1.80, 2.39). Other correlates that significantly predicted HPV series initiation were gender, study year, and intervention arm. Parental attitudes remained a significant predictor of receipt of 3 doses of HPV vaccine along with gender, race, school type and insurance type. This study demonstrates that positive parental attitudes are important predictors of HPV vaccination and critical to increasing coverage rates. Our findings suggest that more research is needed to understand how parental attitudes are developed and evolve over time.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Human papillomavirus vaccination among adolescents in Georgia

Underwood

Weiss

Gargano

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…Although barriers to vaccine uptake are well documented in the literature, particularly among African American females, our study population reported willingness to receive the vaccine when people perceived the vaccine as available at no cost. Reported facilitators of HPV vaccine uptake are knowledge of HPV vaccine [43], higher perceived severity of HPV infection [43][44][45], and having private health insurance [46,47]. Facilitators for both uptake and series completion include unmarried status [35], vaccine history [35,44,46], and subjective norms endorsing HPV vaccination uptake [42,44,[47][48][49].…”

Section: Discussionmentioning

confidence: 99%

A pilot study on the use of a smartphone application to encourage emergency department patients to access preventive services: human papillomavirus vaccine as an example

Hill¹,

Granado²,

Peters³

et al. 2013

Emerg Med Health Care

View full text Add to dashboard Cite

Background: In General, emergency department (ED) personnel are expert in providing episodic care and are usually too busy to attend to patients' need for preventive care. This is the case in the area of administering vaccines particularly when the vaccine protocol requires multiple injections over several months. However, ED personnel recognize the importance of patients receiving preventive services. A possible way for ED personnel to direct patients to prevention services is to use smartphone apps. A pilot study was designed to explore the possibility of using an app to foster the receipt of human papilloma virus (HPV) vaccine. Methods: Women who met the inclusion criteria of (1) Self-identified as African-American, (2) owned a smartphone, and (3) had been cleared for discharge from the ED were recruited to a study to determine their willingness to use a smartphone app with regard to the receipt of the HPV vaccine. They completed a 30 item questionnaire that included questions about demographics, smartphone based questions, HPV knowledge based questions and perception based variables dealing with the acceptability of HPV. Results: Nine of the 19 respondents were willing to participate in a study that would use a smartphone app dealing with HPV. Willingness to participate was significantly related to: 1) participants having health insurance and 2) comfort with HPV messages on a personal phone 3) perceived availability of the HPV vaccine and 4) comfort with an STI smartphone app on their mobile phones. Conclusions: While there is a need for additional research in this area, this pilot study suggest the potential for using smartphones to link ED patients to preventive services. If smartphones lead to additional uptake of vaccines, there is the potential of improving the public's health in other areas of vaccine preventable diseases such as measles, mumps and rubella (MMR), Hepatitis A and B, and influenza vaccines.

show abstract

“…This reflects minimal improvement over the past few years and reaching a plateau for female vaccination at a level dramatically lower than Healthy People 2020's goal of an 80 % completion rate. Site-based studies in the US have reported even lower rates of HPV vaccine completion, ranging between 1.9 and 26.5 % among female adolescents [9][10][11] and between 1.3 and 4 % among male adolescents [12,13].…”

mentioning

confidence: 99%

HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center

et al. 2014

View full text Add to dashboard Cite

Human papillomavirus (HPV) vaccination continues to lag behind other adolescent vaccines, especially in areas with pervasive disparities in HPV-related cancers. The purpose of this study was to examine HPV vaccine completion and dosing intervals among low-income adolescents in urban areas. The study included electronic health record data on HPV vaccination for 872 adolescents who received at least one dose of the HPV vaccine. Only 28.4% completed the 3-dose series. For the whole sample, HPV vaccine completion was higher for non-English speakers and among adolescents seen at Newark-South and East Orange sites. Completion was higher among non-English speaking female and Hispanic adolescents, females seen in Newark-South and East Orange sites, and insured Black adolescents. Completion was also dramatically lower among non-English speaking Black adolescents seen at Newark-North, Irvington, and Orange sites (12.5%) compared to other Black adolescents (22.0-44.4%). The mean dosing intervals were 5.5 months (SD = 4.6) between dose 1 and 2 and 10 months (SD = 6.1) between dose 1 and 3. Longer durations between vaccine doses were found among uninsured adolescents and those seen at Newark-North, Irvington, and Orange sites. Non-English speakers had longer duration between dose 1 and 3. Further, durations between dose 1 and 3 were dramatically longer among insured adolescents seen at Newark-North, Irvington, and Orange locations for the whole sample (M = 11.70; SD = 7.12) and among Hispanic adolescents (M = 13.45; SD = 8.54). Understanding how the study predictors facilitate or impede HPV vaccination is critical to reducing disparities in cervical and other HPV-related cancer, especially among Black, Hispanic, and low-income populations.

show abstract

Understanding Suboptimal Human Papillomavirus Vaccine Uptake Among Ethnic Minority Girls

Cited by 116 publications

References 23 publications

Human papillomavirus vaccination among adolescents in Georgia

Human papillomavirus vaccination among adolescents in Georgia

A pilot study on the use of a smartphone application to encourage emergency department patients to access preventive services: human papillomavirus vaccine as an example

HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center

Contact Info

Product

Resources

About